Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Procept allocates funds for further development of PRO-2000

April 22, 1998

Potential preventive HIV vaccine shows promise in preclinical studies

April 20, 1998

Antiviral drugs advisory committee will discuss NTZ NDA

April 15, 1998

World's first NDA filing for an antisense drug

April 14, 1998

Gilead reports preliminary results from Preveon trials for the treatment of HIV infection

April 14, 1998

Viracept introduced by Roche in most of Japan

April 8, 1998

Gilead broadens HIV expanded access program for Preveon

April 8, 1998

Ligand reports positive results of Panretin phase III trial

April 7, 1998

Novel HIV vaccine available for licensing from NIH

April 6, 1998

IND granted for Enzo Biochem's HGTV43 genetic antisense therapy for AIDS

April 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...